Toggle navigation
Home
Search
Services
Blog
Contact
About
A Randomized Controlled Phase II Clinical Trial of Modulation of Inter-261995129
Johns Hopkins University, Baltimore, MD, United States
Search grants from Johns Hopkins University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
The Glycoproteinoses: Second International Workshop on Advances in Pathogenesis a
Regulation of Sumo Conjugation to the Yeast Septins
Effects of hypoglycemia on cognitive function in children with IDDM
Regulation of Telomere Length in S Cerevisiae
Model Theoretic Semantics, Proof Theoretic Semantics, and Semantically Flavored Syntactic Features
Recently added grants:
Center for Lung Biology and Disease
Atheroprotective Gene Therapy
Mineralocorticoid receptor mediates vascular stiffness via dysregulated immunity in perivascular adipose tissue
Role of LDL receptor family members in protecting the vasculature
Antagonism of the Calcium -Activated Chloride Channel TMEM16A; Beneficial Therapeutic Effects on Airway Epithelium and Smooth Muscle
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA095129-004
Application #
6828932
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Institution
Name
Johns Hopkins University
Department
Type
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Related projects
NIH 2003
N01 CA
A Randomized Controlled Phase II Clinical Trial of Modulation of Inter-261995129
/ Johns Hopkins University
NIH 2002
N01 CA
A Randomized Controlled Phase II Clinical Trial of Modulation of Inter-261995129
/ Johns Hopkins University
Comments
Be the first to comment on this grant